The chemistry and biology of nitroxide compounds

Free Radical Biology and Medicine

Volumn 42, Issue 11, 2007, Pages 1632-1650

  Soule, Benjamin P ^a   Hyodo, Fuminori ^a   Matsumoto, Ken ichiro ^a   Simone, Nicole L ^a   Cook, John A ^a   Krishna, Murali C ^a   Mitchell, James B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Chemoprevention; Contrast agents; Free radicals; Hypertension; Magnetic resonance imaging; Nitroxides; Oxidative stress; Radiation; Tempol

Indexed keywords

CARBOXY PROXYL; HYDROXYLAMINE; NITROXIDE; PEROXIDE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TEMPOL; TEMPOL H; TERT BUTYL HYDROPEROXIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER; CANCER PREVENTION; CYTOTOXICITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG STRUCTURE; FENTON REACTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HYPERTENSION; IONIZING RADIATION; ISCHEMIA; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIATION PROTECTION; RADICAL REACTION; REPERFUSION INJURY; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIOXIDANTS; CELLS; DISEASE; HUMANS; NITROGEN OXIDES; PREVENTIVE MEDICINE; PROTECTIVE AGENTS;

EID: 34247248969     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.02.030     Document Type: Review

References (99)

1. McConnell H.M. In: Berliner L. (Ed). Spin labeling: theory and applications (1976), Academic Press, New York
2. Swartz H.M., Chen K., Pals M., Sentjurc M., and Morse II P.D. Hypoxia-sensitive NMR contrast agents. Magn. Reson. Med. 3 (1986) 169-174
3. Swartz H.M. Principles of the metabolism of nitroxides and their implications for spin trapping. Free Radic. Res. Commun. 9 (1990) 399-405
4. Goldstein S., Samuni A., and Russo A. Reaction of cyclic nitroxides with nitrogen dioxide: the intermediacy of the oxoammonium cations. J. Am. Chem. Soc. 125 (2003) 8364-8370
5. Matsumoto K., Hyodo F., Matsumoto A., Koretsky A.P., Sowers A.L., Mitchell J.B., and Krishna M.C. High-resolution mapping of tumor redox status by magnetic resonance imaging using nitroxides as redox-sensitive contrast agents. Clin. Cancer Res. 12 (2006) 2455-2462
6. Hyodo F., Matsumoto K., Matsumoto A., Mitchell J.B., and Krishna M.C. Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents. Cancer Res. 66 (2006) 9921-9928
7. Samuni A., Krishna C.M., Riesz P., Finkelstein E., and Russo A. A novel metal-free low molecular weight superoxide dismutase mimic. J. Biol. Chem. 263 (1988) 17921-17924
8. Krishna M.C., Grahame D.A., Samuni A., Mitchell J.B., and Russo A. Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc. Natl. Acad. Sci. USA 89 (1992) 5537-5541
9. {radical dot}- or as SOD mimics?. J. Biol. Chem. 271 (1996) 26026-26031
10. Kocherginsky N., and Swartz H. Nitroxide spin labels-reactions in biology and chemistry (1995), CRC Press, Boca Raton, FL
11. Miura Y., Utsumi H., and Hamada A. Antioxidant activity of nitroxide radicals in lipid peroxidation of rat liver microsomes. Arch. Biochem. Biophys. 300 (1993) 148-156
12. Krishna M.C., Samuni A., Taira J., Goldstein S., Mitchell J.B., and Russo A. Stimulation by nitroxides of catalase-like activity of hemeproteins: kinetics and mechanism. J. Biol. Chem. 271 (1996) 26018-26025
13. Mitchell J.B., Samuni A., Krishna M.C., DeGraff W.G., Ahn M.S., Samuni U., and Russo A. Biologically active metal-independent superoxide dismutase mimics. Biochemistry 29 (1990) 2802-2807
14. Milligan J.R., Ng J.Y., Wu C.C., Aguilera J.A., Fahey R.C., and Ward J.F. DNA repair by thiols in air shows two radicals make a double-strand break. Radiat. Res. 143 (1995) 273-280
15. DeGraff W.G., Krishna M.C., Russo A., and Mitchell J.B. Antimutagenicity of a low molecular weight superoxide dismutase mimic against oxidative mutagens. Environ. Mol. Mutagen. 19 (1992) 21-26
16. DeGraff W.G., Krishna M.C., Kaufman D., and Mitchell J.B. Nitroxide-mediated protection against X-ray- and neocarzinostatin-induced DNA damage. Free Radic. Biol. Med. 13 (1992) 479-487
17. Johnstone P.A., DeGraff W.G., and Mitchell J.B. Protection from radiation-induced chromosomal aberrations by the nitroxide Tempol. Cancer 75 (1995) 2323-2327
18. Samuni A., Mitchell J.B., DeGraff W., Krishna C.M., Samuni U., and Russo A. Nitroxide SOD-mimics: modes of action. Free Radic. Res. Commun. 12-13 Pt 1 (1991) 187-194
19. Mitchell J.B., DeGraff W., Kaufman D., Krishna M.C., Samuni A., Finkelstein E., Ahn M.S., Hahn S.M., Gamson J., and Russo A. Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic. Tempol. Arch. Biochem. Biophys. 289 (1991) 62-70
20. Xavier S., Yamada K., Samuni A.M., Samuni A., DeGraff W., Krishna M.C., and Mitchell J.B. Differential protection by nitroxides and hydroxylamines to radiation-induced and metal ion-catalyzed oxidative damage. Biochim. Biophys. Acta 1573 (2002) 109-120
21. Krishna M.C., DeGraff W., Hankovszky O.H., Sar C.P., Kalai T., Jeko J., Russo A., Mitchell J.B., and Hideg K. Studies of structure-activity relationship of nitroxide free radicals and their precursors as modifiers against oxidative damage. J. Med. Chem. 41 (1998) 3477-3492
22. Hahn S.M., Wilson L., Krishna C.M., Liebmann J., DeGraff W., Gamson J., Samuni A., Venzon D., and Mitchell J.B. Identification of nitroxide radioprotectors. Radiat. Res. 132 (1992) 87-93
23. 2-induced damage and their protection by nitroxides. Biochim. Biophys. Acta 1525 (2001) 70-76
24. Samuni A.M., DeGraff W., Cook J.A., Krishna M.C., Russo A., and Mitchell J.B. The effects of antioxidants on radiation-induced apoptosis pathways in TK6 cells. Free Radic. Biol. Med. 37 (2004) 1648-1655
25. Samuni A.M., and Barenholz Y. Stable nitroxide radicals protect lipid acyl chains from radiation damage. Free Radic. Biol. Med. 22 (1997) 1165-1174
26. Dhanasekaran A., Kotamraju S., Karunakaran C., Kalivendi S.V., Thomas S., Joseph J., and Kalyanaraman B. Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide. Free Radic. Biol. Med. 39 (2005) 567-583
27. Xu Y., and Kalyanaraman B. Synthesis and ESR studies of a novel cyclic nitrone spin trap attached to a phosphonium group-A suitable trap for mitochondria-generated ROS?. Free Radic. Res. 41 (2007) 1-7
28. Yamada K., Inoue D., Matsumoto S., and Utsumi H. In vivo measurement of redox status in streptozotocin-induced diabetic rat using targeted nitroxyl probes. Antioxid. Redox Signaling 6 (2004) 605-611
29. Sano H., Naruse M., Matsumoto K., Oi T., and Utsumi H. A new nitroxyl-probe with high retention in the brain and its application for brain imaging. Free Radic. Biol. Med. 28 (2000) 959-969
30. Hahn S.M., Tochner Z., Krishna C.M., Glass J., Wilson L., Samuni A., Sprague M., Venzon D., Glatstein E., Mitchell J.B., et al. Tempol, a stable free radical, is a novel murine radiation protector. Cancer Res. 52 (1992) 1750-1753
31. Liebmann J., DeLuca A.M., Epstein A., Steinberg S.M., Morstyn G., and Mitchell J.B. Protection from lethal irradiation by the combination of stem cell factor and Tempol. Radiat. Res. 137 (1994) 400-404
32. Hahn S.M., Krishna M.C., DeLuca A.M., Coffin D., and Mitchell J.B. Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector. Free Radic. Biol. Med. 28 (2000) 953-958
33. Hahn S.M., Sullivan F.J., DeLuca A.M., Krishna C.M., Wersto N., Venzon D., Russo A., and Mitchell J.B. Evaluation of Tempol radioprotection in a murine tumor model. Free Radic. Biol. Med. 22 (1997) 1211-1216
34. Hahn S.M., DeLuca A.M., Coffin D., Krishna C.M., and Mitchell J.B. In vivo radioprotection and effects on blood pressure of the stable free radical nitroxides. Int. J. Radiat. Oncol. Biol. Phys. 42 (1998) 839-842
35. Vitolo J.M., Cotrim A.P., Sowers A.L., Russo A., Wellner R.B., Pillemer S.R., Mitchell J.B., and Baum B.J. The stable nitroxide Tempol facilitates salivary gland protection during head and neck irradiation in a mouse model. Clin. Cancer Res. 10 (2004) 1807-1812
36. Cotrim A.P., Sowers A.L., Lodde B.M., Vitolo J.M., Kingman A., Russo A., Mitchell J.B., and Baum B.J. Kinetics of Tempol for prevention of xerostomia following head and neck irradiation in a mouse model. Clin. Cancer Res. 11 (2005) 7564-7568
37. Goffman T., Cuscela D., Glass J., Hahn S., Krishna C.M., Lupton G., and Mitchell J.B. Topical application of nitroxide protects radiation-induced alopecia in guinea pigs. Int. J. Radiat. Oncol. Biol. Phys. 22 (1992) 803-806
38. Metz J.M., Smith D., Mick R., Lustig R., Mitchell J., Cherakuri M., Glatstein E., and Hahn S.M. A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy. Clin. Cancer Res. 10 (2004) 6411-6417
39. Halpern H.J., Spencer D.P., and van Polen J. Imaging radio frequency electron-spin-resonance spectrometer with high resolution and sensitivity for in vivo measurements. Rev. Sci. Instrum. 60 (1989) 1040-1050
40. Kuppusamy P., Chzhan M., Vij K., Shteynbuk M., Lefer D.J., Giannella E., and Zweier J.L. Three-dimensional spectral-spatial EPR imaging of free radicals in the heart: a technique for imaging tissue metabolism and oxygenation. Proc. Natl. Acad. Sci. USA 91 (1994) 3388-3392
41. Liu K.J., Gast P., Moussavi M., Norby S.W., Vahidi N., Walczak T., Wu M., and Swartz H.M. Lithium phthalocyanine: a probe for electron paramagnetic resonance oximetry in viable biological systems. Proc. Natl. Acad. Sci. USA 90 (1993) 5438-5442
42. Leunbach I. On a novel MRI technique (OMRI) for the determination of tissue parameters. Acta Anaesthesiol. Scand. Suppl. 110 (1997) 121-122
43. Samuni A., Krishna C.M., Mitchell J.B., Collins C.R., and Russo A. Superoxide reaction with nitroxides. Free Radic. Res. Commun. 9 (1990) 241-249
44. Krishna M.C., and Samuni A. The effect of oxygen at physiological levels on the detection of free radical intermediates by electron paramagnetic resonance. Free Radic. Res. Commun. 18 (1993) 239-247
45. Kuppusamy P., Afeworki M., Shankar R.A., Coffin D., Krishna M.C., Hahn S.M., Mitchell J.B., and Zweier J.L. In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model. Cancer Res. 58 (1998) 1562-1568
46. Ilangovan G., Manivannan A., Li H., Yanagi H., Zweier J.L., and Kuppusamy P. A naphthalocyanine-based EPR probe for localized measurements of tissue oxygenation. Free Radic. Biol. Med. 32 (2002) 139-147
47. Yamada K.I., Kuppusamy P., English S., Yoo J., Irie A., Subramanian S., Mitchell J.B., and Krishna M.C. Feasibility and assessment of non-invasive in vivo redox status using electron paramagnetic resonance imaging. Acta Radiol. 43 (2002) 433-440
48. Kuppusamy P., Li H., Ilangovan G., Cardounel A.J., Zweier J.L., Yamada K., Krishna M.C., and Mitchell J.B. Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Res. 62 (2002) 307-312
49. Sledzinski Z., Wozniak M., Antosiewicz J., Lezoche E., Familiari M., Bertoli E., Greci L., Brunelli A., Mazera N., and Wajda Z. Protective effect of 4-hydroxy-TEMPO, a low molecular weight superoxide dismutase mimic, on free radical toxicity in experimental pancreatitis. Int. J. Pancreatol. 18 (1995) 153-160
50. Dunn J.F., O'Hara J.A., Zaim-Wadghiri Y., Lei H., Meyerand M.E., Grinberg O.Y., Hou H., Hoopes P.J., Demidenko E., and Swartz H.M. Changes in oxygenation of intracranial tumors with carbogen: a BOLD MRI and EPR oximetry study. J. Magn. Reson. Imaging 16 (2002) 511-521
51. Brasch R.C. Work in progress: methods of contrast enhancement for NMR imaging and potential applications. A subject review. Radiology 147 (1983) 781-788
52. Brasch R.C., London D.A., Wesbey G.E., Tozer T.N., Nitecki D.E., Williams R.D., Doemeny J., Tuck L.D., and Lallemand D.P. Work in progress: nuclear magnetic resonance study of a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animals. Radiology 147 (1983) 773-779
53. Brasch R.C., Nitecki D.E., Brant-Zawadzki M., Enzmann D.R., Wesbey G.E., Tozer T.N., Tuck L.D., Cann C.E., Fike J.R., and Sheldon P. Brain nuclear magnetic resonance imaging enhanced by a paramagnetic nitroxide contrast agent: preliminary report. AJR Am. J. Roentgenol. 141 (1983) 1019-1023
54. Berliner L.J., Fujii H., Wan X.M., and Lukiewicz S.J. Feasibility study of imaging a living murine tumor by electron paramagnetic resonance. Magn. Reson. Med. 4 (1987) 380-384
55. Keana J.F., and Pou S. Nitroxide-doped liposomes containing entrapped oxidant: an approach to the "reduction problem" of nitroxides as MRI contrast agents. Physiol. Chem. Phys. Med. NMR 17 (1985) 235-240
56. Mitchell J.B., Xavier S., DeLuca A.M., Sowers A.L., Cook J.A., Krishna M.C., Hahn S.M., and Russo A. A low molecular weight antioxidant decreases weight and lowers tumor incidence. Free Radic. Biol. Med. 34 (2003) 93-102
57. Schubert R., Erker L., Barlow C., Yakushiji H., Larson D., Russo A., Mitchell J.B., and Wynshaw-Boris A. Cancer chemoprevention by the antioxidant Tempol in Atm-deficient mice. Hum. Mol. Genet. 13 (2004) 1793-1802
58. Gueven N., Luff J., Peng C., Hosokawa K., Bottle S.E., and Lavin M.F. Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant. Free Radic. Biol. Med. 41 (2006) 992-1000
59. Erker L., Schubert R., Yakushiji H., Barlow C., Larson D., Mitchell J.B., and Wynshaw-Boris A. Cancer chemoprevention by the antioxidant Tempol acts partially via the p53 tumor suppressor. Hum. Mol. Genet. 14 (2005) 1699-1708
60. Gariboldi M.B., Lucchi S., Caserini C., Supino R., Oliva C., and Monti E. Antiproliferative effect of the piperidine nitroxide TEMPOL on neoplastic and nonneoplastic mammalian cell lines. Free Radic. Biol. Med. 24 (1998) 913-923
61. Cheng W.H., Zheng X., Quimby F.R., Roneker C.A., and Lei X.G. Low levels of glutathione peroxidase 1 activity in selenium-deficient mouse liver affect c-Jun N-terminal kinase activation and p53 phosphorylation on Ser-15 in pro-oxidant-induced aponecrosis. Biochem. J. 370 (2003) 927-934
62. Ito K., Nakazato T., Yamato K., Miyakawa Y., Yamada T., Hozumi N., Segawa K., Ikeda Y., and Kizaki M. Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Res. 64 (2004) 1071-1078
63. Ankel E.G., Lai C.S., Hopwood L.E., and Zivkovic Z. Cytotoxicity of commonly used nitroxide radical spin probes. Life Sci. 40 (1987) 495-498
64. Gariboldi M.B., Rimoldi V., Supino R., Favini E., and Monti E. The nitroxide Tempol induces oxidative stress, p21(WAF1/CIP1); cell death in HL60 cells. Free Radic. Biol. Med. 29 (2000) 633-641
65. Monti E., Supino R., Colleoni M., Costa B., Ravizza R., and Gariboldi M.B. Nitroxide TEMPOL impairs mitochondrial function and induces apoptosis in HL60 cells. J. Cell. Biochem. 82 (2001) 271-276
66. Gariboldi M.B., Ravizza R., Petterino C., Castagnaro M., Finocchiaro G., and Monti E. Study of in vitro and in vivo effects of the piperidine nitroxide Tempol-A potential new therapeutic agent for gliomas. Eur. J. Cancer 39 (2003) 829-837
67. McDonald M.C., Zacharowski K., Bowes J., Cuzzocrea S., and Thiemermann C. Tempol reduces infarct size in rodent models of regional myocardial ischemia and reperfusion. Free Radic. Biol. Med. 27 (1999) 493-503
68. Gelvan D., Saltman P., and Powell S.R. Cardiac reperfusion damage prevented by a nitroxide free radical. Proc. Natl. Acad. Sci. USA 88 (1991) 4680-4684
69. Cuzzocrea S., McDonald M.C., Mazzon E., Siriwardena D., Costantino G., Fulia F., Cucinotta G., Gitto E., Cordaro S., Barberi I., De Sarro A., Caputi A.P., and Thiemermann C. Effects of Tempol, a membrane-permeable radical scavenger, in a gerbil model of brain injury. Brain Res. 875 (2000) 96-106
70. Rak R., Chao D.L., Pluta R.M., Mitchell J.B., Oldfield E.H., and Watson J.C. Neuroprotection by the stable nitroxide Tempol during reperfusion in a rat model of transient focal ischemia. J. Neurosurg. 92 (2000) 646-651
71. Kato N., Yanaka K., Hyodo K., Homma K., Nagase S., and Nose T. Stable nitroxide Tempol ameliorates brain injury by inhibiting lipid peroxidation in a rat model of transient focal cerebral ischemia. Brain Res. 979 (2003) 188-193
72. Kwon T.H., Chao D.L., Malloy K., Sun D., Alessandri B., and Bullock M.R. Tempol, a novel stable nitroxide, reduces brain damage and free radical production, after acute subdural hematoma in the rat. J. Neurotrauma 20 (2003) 337-345
73. Chatterjee P.K., Cuzzocrea S., Brown P.A., Zacharowski K., Stewart K.N., Mota-Filipe H., and Thiemermann C. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int. 58 (2000) 658-673
74. Leach M., Frank S., Olbrich A., Pfeilschifter J., and Thiemermann C. Decline in the expression of copper/zinc superoxide dismutase in the kidney of rats with endotoxic shock: effects of the superoxide anion radical scavenger, Tempol, on organ injury. Br. J. Pharmacol. 125 (1998) 817-825
75. Mota-Filipe H., McDonald M.C., Cuzzocrea S., and Thiemermann C. A membrane-permeable radical scavenger reduces the organ injury in hemorrhagic shock. Shock 12 (1999) 255-261
76. Cuzzocrea S., McDonald M.C., Filipe H.M., Costantino G., Mazzon E., Santagati S., Caputi A.P., and Thiemermann C. Effects of Tempol, a membrane-permeable radical scavenger, in a rodent model of carrageenan-induced pleurisy. Eur. J. Pharmacol. 390 (2000) 209-222
77. Cuzzocrea S., McDonald M.C., Mota-Filipe H., Mazzon E., Costantino G., Britti D., Mazzullo G., Caputi A.P., and Thiemermann C. Beneficial effects of Tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritis. Arthritis Rheum. 43 (2000) 320-328
78. Cuzzocrea S., McDonald M.C., Mazzon E., Dugo L., Lepore V., Fonti M.T., Ciccolo A., Terranova M.L., Caputi A.P., and Thiemermann C. Tempol, a membrane-permeable radical scavenger, reduces dinitrobenzene sulfonic acid-induced colitis. Eur. J. Pharmacol. 406 (2000) 127-137
79. Zamir E., Zhang R., Samuni A., Kogan M., and Pe'er J. Nitroxide stable radical suppresses autoimmune uveitis in rats. Free Radic. Biol. Med. 27 (1999) 7-15
80. Bonnet A.M., and Houeto J.L. Pathophysiology of Parkinson's disease. Biomed. Pharmacother. 53 (1999) 117-121
81. Martinez M., Martinez N., Hernandez A.I., and Ferrandiz M.L. Hypothesis: can N-acetylcysteine be beneficial in Parkinson's disease?. Life Sci. 64 (1999) 1253-1257
82. Merad-Boudia M., Nicole A., Santiard-Baron D., Saille C., and Ceballos-Picot I. Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease. Biochem. Pharmacol. 56 (1998) 645-655
83. Spencer J.P., Jenner P., Daniel S.E., Lees A.J., Marsden D.C., and Halliwell B. Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species. J. Neurochem. 71 (1998) 2112-2122
84. Zhang J., Perry G., Smith M.A., Robertson D., Olson S.J., Graham D.G., and Montine T.J. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am. J. Pathol. 154 (1999) 1423-1429
85. Liang Q., Smith A.D., Pan S., Tyurin V.A., Kagan V.E., Hastings T.G., and Schor N.F. Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson's disease. Biochem. Pharmacol. 70 (2005) 1371-1381
86. Dikalov S.I., Vitek M.P., Maples K.R., and Mason R.P. Amyloid beta peptides do not form peptide-derived free radicals spontaneously, but can enhance metal-catalyzed oxidation of hydroxylamines to nitroxides. J. Biol. Chem. 274 (1999) 9392-9399
87. Sies H. Oxidative stress: oxidants and antioxidants (1991), Academic Press, London
88. Spector A., and Garner W.H. Hydrogen peroxide and human cataract. Exp. Eye Res. 33 (1981) 673-681
89. Reddan J.R., Sevilla M.D., Giblin F.J., Padgaonkar V., Dziedzic D.C., Leverenz V., Misra I.C., and Peters J.L. The superoxide dismutase mimic TEMPOL protects cultured rabbit lens epithelial cells from hydrogen peroxide insult. Exp. Eye Res. 56 (1993) 543-554
90. Reddan J.R., Giblin F.J., Kadry R., Leverenz V.R., Pena J.T., and Dziedzic D.C. Protection from oxidative insult in glutathione depleted lens epithelial cells. Exp. Eye Res. 68 (1999) 117-127
91. Zigler Jr. J.S., Qin C., Kamiya T., Krishna M.C., Cheng Q., Tumminia S., and Russell P. Tempol-H inhibits opacification of lenses in organ culture. Free Radic. Biol. Med. 35 (2003) 1194-1202
92. Zollner S., Haseloff R.F., Kirilyuk I.A., Blasig I.E., and Rubanyi G.M. Nitroxides increase the detectable amount of nitric oxide released from endothelial cells. J. Biol. Chem. 272 (1997) 23076-23080
93. Schnackenberg C.G., Welch W.J., and Wilcox C.S. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32 (1998) 59-64
94. Schnackenberg C.G., and Wilcox C.S. Two-week administration of Tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha. Hypertension 33 (1999) 424-428
95. Hahn S.M., Sullivan F.J., DeLuca A.M., Bacher J.D., Liebmann J., Krishna M.C., Coffin D., and Mitchell J.B. Hemodynamic effect of the nitroxide superoxide dismutase mimics. Free Radic. Biol. Med. 27 (1999) 529-535
96. Patel K., Chen Y., Dennehy K., Blau J., Connors S., Mendonca M., Tarpey M., Krishna M., Mitchell J.B., Welch W.J., and Wilcox C.S. Acute antihypertensive action of nitroxides in the spontaneously hypertensive rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290 (2006) R37-R43
97. McCay C.M., Crowell C.B., and Maynard L.A. The effect of retarded growth upon the length of life span and upon the ultimate body size. J. Nutr. 10 (1935) 63-79
98. Osborne T.B., Mendel L.B., and Ferry E.L. The effect of retardation of growth upon the breeding period and duration of life of rats. Science 45 (1917) 294-295
99. Weindruch R. Caloric restriction and aging. Sci. Am. 274 (1996) 46-52